Hoium calls FTC lawsuit 'nothingburger', sees 13% drop as buying opportunity for largest position
The FTC lawsuit over privacy and billing practices is a minor regulatory headwind that reflects Big Pharma's fear of Hims & Hers becoming the low-cost front door for healthcare, p…